Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
Неврологические проявления у детей и подростков, госпитализированных в США по поводу COVID-19 или мультисистемного воспалительного синдрома
2021-03-05
SCID: 54.1/p842sz3a
Discuss with AI
COVID-19multisystem inflammatory syndrome in childrenneurologic involvementsevere encephalopathystroke
Figures from the paper
Abstract (AI)
Importance: Coronavirus disease 2019 (COVID-19) affects the nervous system in adult patients. The spectrum of neurologic involvement in children and adolescents is unclear. Objective: To understand the range and severity of neurologic involvement among children and adolescents associated with COVID-19. Setting, Design, and Participants: Case series of patients (age <21 years) hospitalized between March 15, 2020, and December 15, 2020, with positive severe acute respiratory syndrome coronavirus 2 test result (reverse transcriptase-polymerase chain reaction and/or antibody) at 61 US hospitals in the Overcoming COVID-19 public health registry, including 616 (36%) meeting criteria for multisystem inflammatory syndrome in children. Patients with neurologic involvement had acute neurologic signs, symptoms, or diseases on presentation or during hospitalization. Life-threatening involvement was adjudicated by experts based on clinical and/or neuroradiologic features. Exposures: Severe acute respiratory syndrome coronavirus 2. Main Outcomes and Measures: Type and severity of neurologic involvement, laboratory and imaging data, and outcomes (death or survival with new neurologic deficits) at hospital discharge. Results: Of 1695 patients (909 [54%] male; median [interquartile range] age, 9.1 [2.4-15.3] years), 365 (22%) from 52 sites had documented neurologic involvement. Patients with neurologic involvement were more likely to have underlying neurologic disorders (81 of 365 [22%]) compared with those without (113 of 1330 [8%]), but a similar number were previously healthy (195 [53%] vs 723 [54%]) and met criteria for multisystem inflammatory syndrome in children (126 [35%] vs 490 [37%]). Among those with neurologic involvement, 322 (88%) had transient symptoms and survived, and 43 (12%) developed life-threatening conditions clinically adjudicated to be associated with COVID-19, including severe encephalopathy (n = 15; 5 with splenial lesions), stroke (n = 12), central nervous system infection/demyelination (n = 8), Guillain-Barré syndrome/variants (n = 4), and acute fulminant cerebral edema (n = 4). Compared with those without life-threatening conditions (n = 322), those with life-threatening neurologic conditions had higher neutrophil-to-lymphocyte ratios (median, 12.2 vs 4.4) and higher reported frequency of D-dimer greater than 3 μg/mL fibrinogen equivalent units (21 [49%] vs 72 [22%]). Of 43 patients who developed COVID-19-related life-threatening neurologic involvement, 17 survivors (40%) had new neurologic deficits at hospital discharge, and 11 patients (26%) died. Conclusions and Relevance: In this study, many children and adolescents hospitalized for COVID-19 or multisystem inflammatory syndrome in children had neurologic involvement, mostly transient symptoms. A range of life-threatening and fatal neurologic conditions associated with COVID-19 infrequently occurred. Effects on long-term neurodevelopmental outcomes are unknown.
Key Findings
1
Among 1,695 hospitalized US patients younger than 21 years with COVID-19 or multisystem inflammatory syndrome, 365 (22%) had documented neurologic involvement.
2
Life-threatening manifestations included severe encephalopathy, sometimes with splenial lesions, and stroke; the abstract reports 15 severe encephalopathy cases and 12 strokes.
3
Most affected patients (322 of 365; 88%) had transient neurologic symptoms and survived, while 43 (12%) developed life-threatening neurologic conditions attributed to COVID-19.
4
Neurologic involvement was associated with preexisting neurologic disorders, present in 22% of affected patients versus 8% without neurologic involvement; however, 53% of affected patients were previously healthy.
5
The findings demonstrate a broad spectrum of neurologic involvement in hospitalized children and adolescents with COVID-19 or multisystem inflammatory syndrome, ranging from transient symptoms to severe disease.
Research Object
Children and adolescents hospitalized in the United States with COVID-19 or multisystem inflammatory syndrome in children
Research Subject
The spectrum, severity, and outcomes of neurologic involvement associated with COVID-19, including transient symptoms and life-threatening neurologic conditions
Publication Details
Publication Date
2021-03-05
Journal
Publisher
ISSN
Cited by
396
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai7
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
Neurological associations of COVID-192020
A first case of meningitis/encephalitis associated with SARS-Coronavirus-22020
Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium2013
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings2020
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series2020
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier2020